<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02069275</url>
  </required_header>
  <id_info>
    <org_study_id>SAMOVAR 01</org_study_id>
    <nct_id>NCT02069275</nct_id>
  </id_info>
  <brief_title>Immediate Mobilization After Cardiac Catheterisation</brief_title>
  <acronym>SAMOVAR</acronym>
  <official_title>Patients Immediate Mobilization After Coronary Angiography and Percutaneous Coronary Intervention. Is it SAfe to MObilize Patients Very eARly After Cardiac Catheterisation?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the frequency of bleeding and haematomas in
      patients undergoing coronary angiography or percutaneous coronary intervention via femoral
      artery and mobilized immediately after the procedure, compared to those mobilized after two
      hours (following the standard regimen). At the same time the investigators will investigate
      whether it reduces the discomfort being mobilized immediately after the procedure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The frequency of hematoma, bleeding or pseudoaneurysm at the access site in the groin is
      7-15% with regimens that involve 0-2 hours of bed rest, somewhat more frequent after
      Percutaneous coronary intervention (PCI) than coronary angiography (CAG). There seems to be
      no reduction in the complications of the CAG or PCI by maintaining the bed rest for more than
      2 hours after the procedure. Angio-Seal seems most effective of current closure devices.
      There is less discomfort associated with early compared with late mobilization. Protamine
      reverse heparin's effect without the side effects of that regime.

      There lacks a larger randomized study of the safety of mobilizing patients immediately after
      CAG and after PCI.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">November 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hematoma&gt; 5 cm</measure>
    <time_frame>participants will be followed for the duration of hospital stay, an expected average of 24 hours</time_frame>
    <description>occurred after the end of the procedure, including retroperitoneal hematoma, bleeding requiring transfusion or pseudoaneurysm that require vascular surgical intervention. Assessed after 30 minutes, after two hours and before discharge</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The presence of hematoma&gt; 10 cm in diameter</measure>
    <time_frame>participants will be followed for the duration of hospital stay, an expected average of 24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The presence of hematoma 2-5 cm in diameter</measure>
    <time_frame>participants will be followed for the duration of hospital stay, an expected average of 24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oozing or bleeding from the puncture site</measure>
    <time_frame>participants will be followed for the duration of hospital stay, an expected average of 24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comfort rating (NRS scale)</measure>
    <time_frame>Two hours after the procedure</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Vascular Access Complication</condition>
  <condition>Comfort</condition>
  <arm_group>
    <arm_group_label>Immediate mobilization</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Immediate mobilization after coronary angiography or percutaneous coronary intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Two hours bedrest</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bedrest two hours after coronary angiography or percutaneous coronary intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Immediate mobilization</intervention_name>
    <description>Patients are mobilized immediate after coronary angiography and percutaneous coronary intervention via femoral access and closed with Angio-seal closing device. Heparin reverted with Protaminsulphate</description>
    <arm_group_label>Immediate mobilization</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Two hours bedrest</intervention_name>
    <description>Patients is following the usual regimen, two hours bedrest after coronary angiography and percutaneous coronary intervention via femoral access and closed with Angio-seal closing device before mobilization. Heparin is reverted with Protaminsulphate</description>
    <arm_group_label>Two hours bedrest</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  CAG or PCI performed via the femoral artery

          -  No hematoma in the groin (&gt; 5 cm in diameter)

          -  Heparin reversed with protamine after PCI

        Exclusion Criteria:

          -  Oozing, bleeding or hematoma

          -  Treatment with Integrilin, ReoPro, or Marevan

          -  Heparin can not be reversed

          -  The patient does not want to participate

          -  Systolic blood pressure &gt; 180 mm Hg after the procedure

          -  BMI&gt; 35 (can be modified if the groin can be assessed in an upright position)

          -  Demented, unconscious patients who do not understand the information for participants.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marianne W Moergaard, MVO</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cardiac Cath.lab. Copenhagen University Hospital, Rigshospitalet, Denmark</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marianne W Noergaard, MVO</last_name>
    <phone>+45 35458869</phone>
    <email>marianne.wetendorff.noergaard@regionh.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jane Faerch, MSc</last_name>
    <phone>+45 35452767</phone>
    <email>jane.faerch.@regionh.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Copenhagen University Hospital, Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <zip>DK-2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marianne W Noergaard, MVO</last_name>
      <phone>+45 35458869</phone>
      <email>marianne.wetendorff.noergaard@regionh.dk</email>
    </contact>
    <contact_backup>
      <last_name>Jane Faerch, MSc</last_name>
      <phone>+45 35452767</phone>
      <email>jane.faerch.@regionh.dk</email>
    </contact_backup>
    <investigator>
      <last_name>Henning Kelbaek, MD, DMSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 13, 2014</study_first_submitted>
  <study_first_submitted_qc>February 19, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 24, 2014</study_first_posted>
  <last_update_submitted>June 30, 2016</last_update_submitted>
  <last_update_submitted_qc>June 30, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 1, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Marianne Wetendorff Noergaard</investigator_full_name>
    <investigator_title>Clinical Nurse Specialist</investigator_title>
  </responsible_party>
  <keyword>Immediate mobilization</keyword>
  <keyword>Bedrest</keyword>
  <keyword>Coronary angiography</keyword>
  <keyword>Coronary percutaneous intervention</keyword>
  <keyword>Vascular access complications</keyword>
  <keyword>Patients comfort</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

